• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

男性强直性脊柱炎患者的动脉粥样硬化:与亚甲基四氢叶酸还原酶(C677T)基因多态性和血浆同型半胱氨酸水平的关系。

Atherosclerosis in male patients with ankylosing spondylitis: the relation with methylenetetrahydrofolate reductase (C677T) gene polymorphism and plasma homocysteine levels.

机构信息

Ankara and Research Hospital, Department of Physical Medicine and Rehabilitation, 06340 Cebeci/Ankara, Turkey.

出版信息

Rheumatol Int. 2013 Jun;33(6):1519-24. doi: 10.1007/s00296-012-2552-8. Epub 2012 Dec 18.

DOI:10.1007/s00296-012-2552-8
PMID:23247802
Abstract

The aim of this study was to determine the intima-media thickness (IMT) in carotid arteries and to assess the relation of these values with plasma homocysteine (pHcy) levels and methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism in patients with Ankylosing spondylitis (AS). Serum lipids, vitamin B12, folic acid, pHcy and acute phase protein levels were measured in all cases. MTHFR C677T gene polymorphisms were determined, and IMT of main carotid artery were evaluated ultrasonographically in all subjects. Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity score and Bath Ankylosing Spondylitis Metrology Index were used to assess disease activity and spinal mobility. Fifty AS patients (mean age of 36.6 ± 4.79 years) and 50 control subjects (36.34 ± 4.72 years) were included in the study. Plasma homocysteine levels of AS patients and control group were also similar (14.26 ± 9.96 vs. 11.81 ± 5.53 μmol/L). Hyperhomocysteinemia was present in 11 subjects in patient group (22.0 %), while it was seen in 5 subjects in the control group (10.0 %). The MTHFR C677T genotype distribution was as follows: CC 31 (62 %), CT 14 (28 %), TT 5 (10 %) in AS patients. The mean carotid IMT values were also found to be similar between the groups. The most important factor influencing pHcy level was found as MTHFR 677TT genotype. We indicated no difference of atherosclerosis indices revealed by IMT values and pHcy levels AS patients and control subjects. But an association between MTHFR 677 gene polymorphism and pHcy levels was concluded, which may suggest that MTHFR 677 TT polymorphism may be a potential prognostic factor for cardiovascular disease in patients with AS.

摘要

本研究旨在测定颈总动脉内-中膜厚度(IMT),评估其与血清同型半胱氨酸(pHcy)水平和亚甲基四氢叶酸还原酶(MTHFR)C677T 基因多态性的关系。所有患者均测定血脂、维生素 B12、叶酸、pHcy 和急性期蛋白水平,所有受试者均行颈动脉超声检查评估 MTHFR C677T 基因多态性和主要颈动脉内-中膜厚度。采用 Bath 强直性脊柱炎疾病活动指数、强直性脊柱炎疾病活动评分和 Bath 强直性脊柱炎测量指数评估疾病活动度和脊柱活动度。本研究纳入 50 例强直性脊柱炎患者(平均年龄 36.6 ± 4.79 岁)和 50 例对照组(平均年龄 36.34 ± 4.72 岁)。结果显示,两组患者 pHcy 水平相似(14.26 ± 9.96 vs. 11.81 ± 5.53 μmol/L)。患者组中 11 例(22.0%)存在高同型半胱氨酸血症,对照组中 5 例(10.0%)存在高同型半胱氨酸血症。MTHFR C677T 基因型分布为:CC 31 例(62%)、CT 14 例(28%)、TT 5 例(10%)。两组颈动脉 IMT 值相似。结果显示,影响 pHcy 水平的最重要因素是 MTHFR 677TT 基因型。本研究表明,AS 患者和对照组的 IMT 值和 pHcy 水平的动脉粥样硬化指标无差异。但得出 MTHFR 677 基因多态性与 pHcy 水平之间存在关联的结论,这提示 MTHFR 677TT 多态性可能是 AS 患者心血管疾病的潜在预后因素。

相似文献

1
Atherosclerosis in male patients with ankylosing spondylitis: the relation with methylenetetrahydrofolate reductase (C677T) gene polymorphism and plasma homocysteine levels.男性强直性脊柱炎患者的动脉粥样硬化:与亚甲基四氢叶酸还原酶(C677T)基因多态性和血浆同型半胱氨酸水平的关系。
Rheumatol Int. 2013 Jun;33(6):1519-24. doi: 10.1007/s00296-012-2552-8. Epub 2012 Dec 18.
2
Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis.亚甲基四氢叶酸还原酶基因多态性:其对接受血液透析的终末期肾病患者血浆同型半胱氨酸水平及颈动脉粥样硬化的影响。
Nephron. 2001 Mar;87(3):249-56. doi: 10.1159/000045922.
3
Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.亚甲基四氢叶酸还原酶C677T多态性与亚临床动脉粥样硬化标志物的关联:芬兰年轻人心血管风险研究
Scand J Clin Lab Invest. 2008;68(1):22-30. doi: 10.1080/00365510701487735. Epub 2007 Nov 21.
4
Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian, Chinese and European Canadians.南亚裔、华裔和加拿大欧洲裔人群中血浆同型半胱氨酸及亚甲基四氢叶酸还原酶C677T基因多态性与颈动脉内膜中层厚度的相关性
Atherosclerosis. 2004 Oct;176(2):361-70. doi: 10.1016/j.atherosclerosis.2004.06.003.
5
Correlation between C677T MTHFR gene polymorphism, plasma homocysteine levels and the incidence of CAD.C677T亚甲基四氢叶酸还原酶(MTHFR)基因多态性、血浆同型半胱氨酸水平与冠心病发病率之间的相关性
Am J Cardiovasc Drugs. 2001;1(5):353-61. doi: 10.2165/00129784-200101050-00005.
6
The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.亚甲基四氢叶酸还原酶基因C677T突变、血浆同型半胱氨酸浓度与冠状动脉疾病风险
Kardiol Pol. 2003 Jul;59(7):17-26; discussion 26.
7
A Potential Strategy for Atherosclerosis Prevention in Modernizing China - Hyperhomocysteinemia, MTHFR C677T Polymorphism and Air Pollution (PM2.5) on Atherogenesis in Chinese Adults.中国现代化进程中动脉粥样硬化预防的潜在策略——高同型半胱氨酸血症、MTHFR C677T 多态性与大气污染(PM2.5)对中国成年人动脉粥样硬化形成的影响。
J Nutr Health Aging. 2023;27(2):134-141. doi: 10.1007/s12603-023-1889-x.
8
Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.亚甲基四氢叶酸还原酶基因C677T和A1298C多态性、血浆同型半胱氨酸、叶酸和维生素B12水平与冠状动脉疾病的程度
Am J Cardiol. 2004 May 15;93(10):1201-6. doi: 10.1016/j.amjcard.2004.02.009.
9
Influence of MTHFR C677T gene polymorphism in the development of cardiovascular disease in Egyptian patients with rheumatoid arthritis.MTHFR C677T基因多态性对埃及类风湿关节炎患者心血管疾病发生发展的影响。
Gene. 2017 Apr 30;610:127-132. doi: 10.1016/j.gene.2017.02.015. Epub 2017 Feb 12.
10
Contribution of MTHFR gene variants in lupus related subclinical atherosclerosis.亚临床动脉粥样硬化与 MTHFR 基因突变的相关性研究。
Clin Immunol. 2018 Aug;193:110-117. doi: 10.1016/j.clim.2018.02.014. Epub 2018 Mar 6.

引用本文的文献

1
Association of homocysteine with ankylosing spondylitis: a systematic review and meta-analysis.同型半胱氨酸与强直性脊柱炎的相关性:系统评价和荟萃分析。
Adv Rheumatol. 2021 Mar 10;61(1):17. doi: 10.1186/s42358-021-00175-7.
2
Prevalence of Subclinical Carotid Atherosclerosis and Vitamin D Deficiency in Egyptian Ankylosing Spondylitis Patients.埃及强直性脊柱炎患者亚临床颈动脉粥样硬化和维生素D缺乏症的患病率
Arch Rheumatol. 2020 Feb 7;35(3):335-342. doi: 10.46497/ArchRheumatol.2020.7694. eCollection 2020 Sep.
3
The Role of Polymorphism Gen in Ischaemic Stroke Patients with and Without Hypertension.

本文引用的文献

1
The Frequency of A1298C and C677T Polymorphisms of the Methylentetrahydrofolate Gene in Turkish Patients with Rheumatoid Arthritis: Relationship with Methotrexate Toxicity.土耳其类风湿关节炎患者亚甲基四氢叶酸还原酶基因A1298C和C677T多态性的频率:与甲氨蝶呤毒性的关系
Open Rheumatol J. 2011;5:30-5. doi: 10.2174/1874312901105010030. Epub 2011 Oct 14.
2
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores.强直性脊柱炎疾病活动评分 (ASDAS):确定疾病活动状态和改善评分的临界值。
Ann Rheum Dis. 2011 Jan;70(1):47-53. doi: 10.1136/ard.2010.138594. Epub 2010 Nov 10.
3
多态性基因在有高血压和无高血压的缺血性中风患者中的作用。
Open Access Maced J Med Sci. 2019 Jan 4;7(1):29-32. doi: 10.3889/oamjms.2019.026. eCollection 2019 Jan 15.
4
Carotid Intima-Media Thickness in Patients with Ankylosing Spondylitis: A Systematic Review and Updated Meta-Analysis.强直性脊柱炎患者的颈动脉内膜中层厚度:系统评价和更新的荟萃分析。
J Atheroscler Thromb. 2019 Mar 1;26(3):260-271. doi: 10.5551/jat.45294. Epub 2018 Aug 8.
5
Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS.血浆致动脉粥样硬化指数:强直性脊柱炎亚临床动脉粥样硬化的有用标志物:AIP 与 AS 中的 cIMT 相关。
Clin Rheumatol. 2018 May;37(5):1273-1280. doi: 10.1007/s10067-018-4027-0. Epub 2018 Feb 12.
6
Effect of MTHFR Gene Polymorphism Impact on Atherosclerosis via Genome-Wide Methylation.亚甲基四氢叶酸还原酶(MTHFR)基因多态性通过全基因组甲基化对动脉粥样硬化的影响
Med Sci Monit. 2016 Feb 1;22:341-5. doi: 10.12659/msm.895296.
Plasma asymmetric dimethylarginine (ADMA) levels and atherosclerotic disease in ankylosing spondylitis: a cross-sectional study.
强直性脊柱炎患者血浆非对称性二甲基精氨酸水平与动脉粥样硬化疾病:一项横断面研究。
Clin Rheumatol. 2011 Jan;30(1):21-7. doi: 10.1007/s10067-010-1589-x. Epub 2010 Oct 14.
4
Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis.强直性脊柱炎患者的动脉粥样硬化前期加速迹象。
J Rheumatol. 2010 Jan;37(1):161-6. doi: 10.3899/jrheum.090667. Epub 2009 Dec 1.
5
Methylenetetrahydrofolate reductase polymorphisms and methotrexate: no association with response to therapy nor with drug-related adverse events in an Italian population of rheumatic patients.亚甲基四氢叶酸还原酶基因多态性与甲氨蝶呤:在意大利风湿性疾病患者群体中,与治疗反应及药物相关不良事件均无关联。
Clin Exp Rheumatol. 2009 May-Jun;27(3):499-502.
6
Serum homocysteine level in patients with ankylosing spondylitis.血清同型半胱氨酸水平与强直性脊柱炎。
Rheumatol Int. 2009 Oct;29(12):1435-9. doi: 10.1007/s00296-009-0875-x. Epub 2009 Mar 15.
7
Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.外周动脉疾病与亚甲基四氢叶酸还原酶(MTHFR)C677T突变:一项病例对照研究及荟萃分析。
J Vasc Surg. 2009 Mar;49(3):711-8. doi: 10.1016/j.jvs.2008.10.004. Epub 2009 Jan 21.
8
Aortic involvement in ankylosing spondylitis.强直性脊柱炎中的主动脉受累情况。
Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S131-4.
9
Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables.强直性脊柱炎患者的高同型半胱氨酸血症:患病率及其与临床变量的关联
Rheumatol Int. 2008 Oct;28(12):1223-8. doi: 10.1007/s00296-008-0687-4. Epub 2008 Aug 22.
10
Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease.在无临床明显心血管疾病的强直性脊柱炎患者中,动脉僵硬度增加或内膜中层厚度增加的趋势。
Rheumatology (Oxford). 2008 Aug;47(8):1203-7. doi: 10.1093/rheumatology/ken198. Epub 2008 Jun 4.